GSK and Vir announce EMA review of VIR-7831 for early treatment of Covid-19

Ahead of any formal Marketing Authorisation Application (MAA), the review will assist in EU-wide recommendations for countries that may take evidence-based decisions on the premature use of the medicine.Credit: Mohamed Hassan/Pixabay.